
Healthcare / Life Sciences · NSE / BSE
Founded in 1998, Indegene Limited is a leading digital solutions provider for the life sciences industry, helping companies with everything from drug development and clinical trials to regulatory submissions and sales & marketing. The company offers a wide range of services through its Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Enterprise Clinical Solutions, along with expert consultancy. Its subsidiary, DT Consulting, specializes in guiding life sciences firms through digital transformation to enhance customer experiences. Indegene has also been recognized for its workplace excellence, winning the Platinum Level award at the 2023 Healthy Workplace Conference and Awards. With a global team of 5,181 professionals and 65 active clients across India, North America, Europe, China, and beyond, Indegene continues to deliver innovative and impactful solutions for the life sciences sector.
Price Band
₹430 – ₹452
Issue Size
₹1842 Cr
Lot Size
33 shares
GMP
+60.8%
Est. Listing
₹727
at current GMP
Subscribed
70.26x
overall
Open
6 May 2024
Close
8 May 2024
Allotment
10 May 2024
Refund
11 May 2024
Demat Credit
12 May 2024
Listing
13 May 2024
Designated Registrar: Link Intime India Private Limited
Allotment Date
10 May 2024
Basis finalization
Refunds Initiate
11 May 2024
Mandate release
Demat Credit
12 May 2024
Shares in demat
Listing Debut
13 May 2024
Trading begins
Indegene Limited is bringing an initial public offering (IPO) in the Healthcare / Life Sciences sector with an aggregate issue size of ₹1,841.76 Crores. The shares are offered at a price band of ₹430 to ₹452 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 33 shares (approx. ₹14,916 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-05-12, while un-allotted funds or UPI block mandates will be released on 2024-05-11.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.